Dolphin Medical

Is Dolphin Medical overvalued or undervalued?

As of November 12, 2024, Dolphin Medical's valuation has deteriorated to "risky," with negative financial ratios indicating overvaluation and poor performance compared to peers like Max Healthcare and Apollo Hospitals, alongside a recent stock decline of 3.36%.

As of 12 November 2024, Dolphin Medical's valuation grade has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued based on its current financial ratios, which include a PE ratio of -3.58, an EV to EBITDA of -4.38, and a Price to Book Value of 0.35. These figures suggest that the company is struggling to generate positive earnings and is not effectively utilizing its assets.<BR><BR>When compared to its peers, Dolphin Medical's financial metrics starkly contrast with those of Max Healthcare, which has a PE ratio of 100.29, and Apollo Hospitals, with a PE ratio of 69.03. This highlights the significant gap in valuation and operational performance within the healthcare services sector. Additionally, Dolphin Medical's recent stock performance has lagged behind the Sensex, with a 1-week return of -3.36%, further reinforcing the notion that the company is currently overvalued in the market.

What is the technical trend for Dolphin Medical?

As of January 21, 2025, Dolphin Medical's technical trend is mildly bullish, supported by daily moving averages and monthly indicators, despite some bearish signals from the weekly MACD and Bollinger Bands.

As of 21 January 2025, the technical trend for Dolphin Medical has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD remains bullish. The daily moving averages show a mildly bullish trend, suggesting some short-term strength. However, the weekly Bollinger Bands are bearish, which adds caution. The KST and OBV on a monthly basis are both bullish, supporting the mildly bullish outlook. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and monthly indicators.

Who are in the management team of Dolphin Medical?

As of March 2020, the management team of Dolphin Medical includes G V Mohan Prasad (Managing Director & CEO), M Lakshmi Sudha (Whole Time Director & CFO), and five non-executive directors: Vinay Vishnuraj Nayak, Narendra Seena Karkera, K Ramana Kumar, along with executive directors Nanapaneni Buddha Sagar and Madala Sesha Ratnam.

As of March 2020, the management team of Dolphin Medical includes the following members:<BR><BR>1. G V Mohan Prasad - Managing Director & CEO<BR>2. M Lakshmi Sudha - Whole Time Director & CFO<BR>3. Vinay Vishnuraj Nayak - Non-Executive & Independent Director<BR>4. Narendra Seena Karkera - Non-Executive & Independent Director<BR>5. K Ramana Kumar - Non-Executive & Independent Director<BR>6. Nanapaneni Buddha Sagar - Executive Director<BR>7. Madala Sesha Ratnam - Executive Director<BR><BR>These individuals play key roles in the governance and operational leadership of the company.

What does Dolphin Medical do?

Dolphin Medical Services Ltd is a micro-cap healthcare company established in 1992, primarily operated by doctors from Andhra Pradesh. As of March 2025, it reported net sales of 1 Cr and a net loss of 1 Cr, with a market cap of INR 3 Cr.

Overview: <BR>Dolphin Medical Services Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Dolphin Medical Services Limited was established in September 1992 and is promoted by doctors from the coastal region of Andhra Pradesh. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -1 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 3 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 81 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.08 <BR>Return on Equity: -1.67% <BR>Price to Book: 0.32<BR><BR>Contact Details: <BR>Address: # No 417 Sanali Heavens, Ameerpet Hyderabad Telangana : 500073 <BR>Tel: 91-040-23738877 <BR>Email: dolphinmedicalindia@gmail.com <BR>Website: http://www.dolphinmedicalservices.com

Who are the top shareholders of the Dolphin Medical?

The top shareholder of Dolphin Medical is G V Mohan Prasad, with a 12.71% stake, followed by public shareholder Manish Ramanlal Shah at 1.68%. Individual investors hold a combined 69.81% of the shares, with no institutional or pledged promoter holdings reported.

The top shareholders of Dolphin Medical include G V Mohan Prasad, who holds the highest stake at 12.71%. The highest public shareholder is Manish Ramanlal Shah, with a holding of 1.68%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 69.81% of the shares. There are no institutional holdings or pledged promoter holdings reported.

When is the next results date for Dolphin Medical?

The next results date for Dolphin Medical is January 30, 2026.

The next results date for Dolphin Medical is scheduled for January 30, 2026.

Why is Dolphin Medical Services Ltd falling/rising?

As of 26-Mar, Dolphin Medical Services Ltd's stock price is stable at Rs. 4.65, but it has shown significant growth, rising 62.02% year-to-date and 107.59% over the past year, while outperforming its sector. The stock is trading above all moving averages, indicating a strong upward trend despite a decline in the broader sector.

As of 26-Mar, Dolphin Medical Services Ltd's stock price is currently stable at Rs. 4.65, showing no change (0.00%). However, the stock has demonstrated significant upward momentum over various periods. Over the past week, the stock has risen by 4.97%, while in the last month, it has increased by 21.41%. Year-to-date, the stock has surged by 62.02%, and over the past year, it has experienced a remarkable rise of 107.59%. <BR><BR>Today, the stock reached a new 52-week high of Rs. 4.65 and has outperformed its sector by 7.37%. Additionally, it is trading above all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong upward trend. The stock has also seen a notable increase in investor participation, with delivery volume rising by 115.96% compared to the 5-day average.<BR><BR>Despite the overall decline in the Hospital & Healthcare Services sector, which has fallen by 2.37%, Dolphin Medical Services Ltd has managed to maintain its positive trajectory, supported by strong performance metrics and rising investor interest. This combination of factors contributes to the stock's rising trend, despite its current price stability.

Why is Dolphin Medical Services Ltd falling/rising?

As of 27-Mar, Dolphin Medical Services Ltd is stable at Rs. 4.65, with a recent upward trend of 4.97% in the past week and 62.02% year-to-date. The stock has outperformed the Sensex and its sector, indicating strong market performance and rising investor confidence.

As of 27-Mar, Dolphin Medical Services Ltd is experiencing a stable stock price at Rs. 4.65, with no change recorded today. However, the stock has shown significant upward momentum in recent periods. Over the past week, the stock has risen by 4.97%, while it has increased by 21.41% over the past month and an impressive 62.02% year-to-date. Additionally, the stock has reached a new 52-week high today, indicating strong performance.<BR><BR>The stock's performance has notably outpaced the benchmark Sensex, which has declined by 1.27% over the past week and 9.48% over the past month. Furthermore, Dolphin Medical has outperformed its sector by 7.37% today, highlighting its relative strength in the market. The stock is also trading above its moving averages across various time frames, suggesting a bullish trend.<BR><BR>Investor interest appears to be rising, as evidenced by a significant increase in delivery volume, which rose by 115.96% against the 5-day average. This indicates growing confidence among investors. Despite some erratic trading patterns, with the stock not trading on four days out of the last twenty, the overall indicators suggest a positive outlook for Dolphin Medical Services Ltd.

Why is Dolphin Medical Services Ltd falling/rising?

As of 28-Mar, Dolphin Medical Services Ltd's stock price is stable at 4.65, with significant upward trends over various periods, including a year-to-date increase of 62.02% and a 107.59% rise over the past year. The stock has outperformed its sector and shows strong investor interest, despite some erratic trading patterns.

As of 28-Mar, Dolphin Medical Services Ltd is experiencing a stable stock price of 4.65, with no change recorded today. However, the stock has shown significant upward movement over various periods, indicating a strong overall performance. Over the past week, the stock has risen by 4.97%, and in the last month, it has increased by 21.41%. Year-to-date, the stock has surged by 62.02%, and over the past year, it has achieved an impressive 107.59% increase. <BR><BR>Today, the stock reached a new 52-week high of Rs. 4.65 and has outperformed its sector by 7.37%. Additionally, Dolphin Medical is trading above its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bullish trend. <BR><BR>Investor participation has also increased, with a notable rise in delivery volume by 115.96% compared to the 5-day average, suggesting growing interest in the stock. Despite some erratic trading patterns, where the stock did not trade on 4 out of the last 20 days, the overall liquidity remains sufficient for trading. <BR><BR>In contrast, the broader Hospital & Healthcare Services sector has declined by 2.37%, highlighting that Dolphin Medical's performance is particularly strong relative to its peers. This combination of factors contributes to the stock's rising trend, despite the current price stability.

Why is Dolphin Medical Services Ltd falling/rising?

As of 29-Mar, Dolphin Medical Services Ltd's stock price is stable at Rs. 4.65, with a significant upward trend reflected in a 62.02% year-to-date increase and a 107.59% rise over the past year. Despite sector declines, strong performance metrics and increased investor interest support its positive trajectory.

As of 29-Mar, Dolphin Medical Services Ltd's stock price is currently stable at Rs. 4.65, showing no change (0.00%). However, the stock has demonstrated a significant upward trend over various periods. Over the past week, the stock has increased by 4.97%, while in the last month, it has risen by 21.41%. Year-to-date, the stock has surged by 62.02%, and over the past year, it has achieved an impressive growth of 107.59%. <BR><BR>Today, the stock reached a new 52-week high of Rs. 4.65 and outperformed its sector by 7.37%. This positive performance is further supported by the fact that Dolphin Medical is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward momentum. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 115.96% compared to the 5-day average, suggesting heightened interest in the stock.<BR><BR>Despite the overall decline in the Hospital & Healthcare Services sector, which fell by 2.37%, Dolphin Medical's strong performance metrics and rising investor engagement contribute to its current price stability and overall positive trajectory.

Which are the latest news on Dolphin Medical?

Which are the latest news on Dolphin Medical?

Which are the latest news on Dolphin Medical?